Shelter Pharma Board approves FY26 audited results, appoints internal auditor

Shelter Pharma Limited's Board of Directors convened on May 28, 2026, to approve the Standalone Audited Financial Results for the half year and full year ended March 31, 2026. The results, submitted under SEBI (LODR) Regulation 33, include an Auditor's Report with an unmodified opinion. Additionally, the Board appointed CA Ismail Ibrahimbhai Lakhani (M/S. I I LAKHANI & CO) as the Internal Auditors for the financial year 2026-27. The company has enclosed the financial statements, auditor's report, and the internal auditor's brief profile.